Entity

Time filter

Source Type


Fujiwara K.,Kitakyushu Municipal Wakamatsu Hospital | Nakahara C.,Kitakyushu Municipal Wakamatsu Hospital | Yamasaki T.,Kitakyushu Municipal Wakamatsu Hospital | Iwashita T.,Kitakyushu Municipal Wakamatsu Hospital
Journal of Gastrointestinal Cancer | Year: 2010

Introduction Aberrant pancreas in the jejunum is a rare condition, and its malignant transformation is very unusual. Case report We presented a case in which jejunal carcinoma occurred in the aberrant pancreas. A 76-year-old woman was admitted to our hospital due to repetitive vomiting after meals. Radiology showed high obstruction in the proximal jejunum. Laparotomy revealed that the obstruction was a submucosal tumor. Partial resection of the jejunum including the tumor was performed. Histology showed that the tumor was made up of well-differentiated adenocarcinoma originating from aberrant pancreatic tissues. Conclusion This was the tenth case of aberrant pancreatic carcinoma in the jejunum reported in literature. © Humana Press Inc. 2009. Source


Fujiwara K.,Kitakyushu Municipal Wakamatsu Hospital | Nagayoshi Y.,Kitakyushu Municipal Wakamatsu Hospital | Nakahara C.,Kitakyushu Municipal Wakamatsu Hospital | Yamasaki T.,Kitakyushu Municipal Wakamatsu Hospital | Iwashita T.,Kitakyushu Municipal Wakamatsu Hospital
Japanese Journal of Cancer and Chemotherapy | Year: 2011

We report a case of undifferentiated colon cancer treated with FOLFIRI therapy. A 69-year-old male had suffered from descending colon cancer. He underwent a left hemicolectomy with D3 dissection. Histopathologically, the tumor was undifferentiated carcinoma, and the cytology of ascites was positive. Peritoneal disseminations occurred soon after surgery, and these tumors did not respond to FOLFOX4 therapy. FOLFIRI therapy was employed, and it reduced the size of these tumors once. However, the therapy failed to control the tumor progression 2 months later. Although we started bevacizumab and S-1, the patient died 11 months after the operation. The present case demonstrates the efficacy of FOLFIRI therapy for undifferentiated colon cancer. Source

Discover hidden collaborations